Lv1
60 积分 2026-03-04 加入
CAR T-cell therapy for multiple myeloma: state of the art and prospects
9天前
已完结
A novel triple-knockout allogeneic BCMA CAR T cell therapy (CT0590) in multiple myeloma: preclinical and phase I study
23天前
已完结
109 Dominant-negative TGFβ receptor 2 enhances GPC3-targeting CAR-T cell efficacy against hepatocellular carcinoma
27天前
已完结
Rational design of TGFbRII dominant negative armored GPC3 CAR-T cells for the treatment of hepatocellular carcinoma
27天前
已关闭
Leveraging T cell-specific fusogenicity of HIV for in vivo mRNA delivery to produce human CAR-T cells
1个月前
已完结
The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment
1个月前
已完结
Generation of a humanized anti-glypican 3 antibody by CDR grafting and stability optimization
1个月前
已完结
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers
1个月前
已完结
A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapy
3个月前
已完结
Systemic reprogramming of tumour immunity via IL-10-mRNA nanoparticles
3个月前
已完结
皖公网安备34019202002308
